Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

WuXi Biologics (2269)

Hong Kong
Currency in HKD
Disclaimer
13.48
+0.74(+5.81%)
Closed

2269 Comments

Nomura Axes WUXI BIO TP to $95.75, Rating Buy
What’s happen?
M Stanley Foresees WUXI BIO Shr Rise in 30 Days, Rated Overweight with $175 TP
Daiwa Adds WUXI BIO TP to $167; Rated*** ***Buy
C Suisse Hikes WUXI BIO TP to $158, Rated ***Outperform***
Goldman Sachs Increases TP to $131.4 Rated BUY ! 👍🏻
JPM Hikes WUXI BIO TP to $130; Rated ***Overweight***
Nomura Chops WUXI BIO TP to $116.8, Rated ***Buy***
Definitely will back to 120 by end of this year. Company future is very good. Next factory to be setup to increase capacity expansion is ongoing till 2023. Stay tune for the extraordinary earning in the coning years. Surely a high growth positive cashflow company in China 👍🏻
Daiwa: WUXI BIO ( Share Correction Overdone Entails Bottom-fish Odds, Restated ***Buy***
This is oversold. Buy the dip
C Suisse: WUXI BIO Share Price Likely Bumpy on Vir COVID Neutrializing Antibody Clinical Trial Failure
WUXI BIO Mulls Placing Shrs at Nearly 7% Discount, Net Proceeds Expected to Top $13.1B***jm
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.